Neisseria Meningitidis Burden of Disease Study

CompletedOBSERVATIONAL
Enrollment

521

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Streptococcus PneumoniaeNeisseria MeningitidisHaemophilus Influenzae
Interventions
OTHER

Data collection

Collection of demographic data and vaccination history

OTHER

CSF samples testing

CSF samples will be tested for the determination of N. meningitidis and other likely bacterial pathogens that cause bacterial meningitis (S. pneumoniae and H. influenzae)

Trial Locations (3)

1102

GSK Investigational Site, Quezon City

2600

GSK Investigational Site, Baguio City, Benguet

084

GSK Investigational Site, Hanoi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01730391 - Neisseria Meningitidis Burden of Disease Study | Biotech Hunter | Biotech Hunter